Keurig Dr Pepper, Inc $KDP Stake Lessened by Allspring Global Investments Holdings LLC

Key Points

• Allspring Global Investments cut its Keurig Dr Pepper stake by 0.3%, selling 39,152 shares in the third quarter. It retained 12.83 million shares, valued at about $393.8 million.
• KDP reported quarterly EPS of $0.66, beating the $0.62 consensus, while revenue of $7.34 billion slightly topped estimates and rose 70.6% year over year.
• Analyst sentiment is moderately positive: 10 analysts rate the shares Buy and nine Hold, with a consensus price target of $37.29. The article also notes growth in beverage and energy brands alongside weaker coffee demand and a planned 2027 business split.

Allspring Global Investments Holdings LLC trimmed its stake in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 0.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,830,932 shares of the company's stock after selling 39,152 shares during the period. Keurig Dr Pepper makes up 0.6% of Allspring Global Investments Holdings LLC's investment portfolio, making the stock its 26th largest holding. Allspring Global Investments Holdings LLC owned about 0.94% of Keurig Dr Pepper worth $393,781,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of KDP. BlackRock Inc. purchased a new position in Keurig Dr Pepper during the 2nd quarter worth approximately $4,697,645,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in Keurig Dr Pepper in the second quarter valued at approximately $767,105,000. Dimensional Fund Advisors LP lifted its stake in Keurig Dr Pepper by 1.1% in the first quarter. Dimensional Fund Advisors LP now owns 9,585,791 shares of the company's stock valued at $252,408,000 after buying an additional 103,505 shares during the last quarter. Bank of America Corp DE acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $281,503,000. Finally, Legal & General Group Plc acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $269,336,000. 93.99% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Keurig Dr Pepper

Here are the key news stories impacting Keurig Dr Pepper this week:

• Positive Sentiment: Ghost Energy has become KDP’s fourth brand with more than $1 billion in annual sales, reinforcing the scale of its energy-drink business and adding to its growth story. Ghost Energy becomes Keurig Dr Pepper’s fourth $1 billion brand
• Positive Sentiment: Analyst actions provide additional support: Barclays raised its target to $41 and kept an overweight rating, while UBS raised its target to $42 and maintained a buy rating. Higher targets suggest analysts see further potential in the shares. Barclays price target UBS price target
• Neutral Sentiment: KDP’s planned 2027 split could help investors value its beverage and coffee businesses separately. However, recent results point to a mixed outlook: beverage and energy growth contrasts with weaker coffee demand, leaving open whether the separation will create value. Keurig Dr Pepper's Beverage Growth Raises a Tough Question About Its Coffee Split Analysts weigh split plans
• Neutral Sentiment: A comparison of beverage companies’ dividend prospects raises questions about payout resilience and financial cushions, but the supplied headline does not specify a KDP-specific conclusion. Dividend comparison of Coca-Cola, PepsiCo and Keurig Dr Pepper

Keurig Dr Pepper Stock Performance

NASDAQ KDP opened at $36.63 on Monday. The company has a quick ratio of 0.32, a current ratio of 0.52 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $49.85 billion, a P/E ratio of 33.61, a P/E/G ratio of 1.75 and a beta of 0.35. Keurig Dr Pepper, Inc has a 52-week low of $24.88 and a 52-week high of $37.88. The firm has a 50-day moving average price of $32.87 and a 200 day moving average price of $30.20.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.62 by $0.04. Keurig Dr Pepper had a return on equity of 11.27% and a net margin of 7.12%. The company had revenue of $7.34 billion for the quarter, compared to analyst estimates of $7.33 billion. During the same quarter in the previous year, the company earned $0.54 EPS. The firm's revenue for the quarter was up 70.6% compared to the same quarter last year. Equities research analysts expect that Keurig Dr Pepper, Inc will post 2.31 EPS for the current year.

Keurig Dr Pepper Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 9th. Investors of record on Monday, September 28th were paid a $0.23 dividend. The ex-dividend date was Monday, September 28th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.5%. Keurig Dr Pepper's payout ratio is 84.40%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. BNP Paribas Exane lifted their price objective on shares of Keurig Dr Pepper from $28.00 to $29.00 and gave the company a "neutral" rating in a research note on Monday, August 10th. Piper Sandler reiterated an "overweight" rating on shares of Keurig Dr Pepper in a research note on Wednesday, October 14th. Morgan Stanley boosted their price target on Keurig Dr Pepper from $38.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, November 4th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Keurig Dr Pepper in a research note on Wednesday. Finally, JPMorgan Chase & Co. upped their price objective on Keurig Dr Pepper from $39.00 to $41.00 and gave the company an "overweight" rating in a research note on Wednesday, November 4th. Ten investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Keurig Dr Pepper presently has a consensus rating of "Moderate Buy" and an average target price of $37.29.

Insider Activity at Keurig Dr Pepper

In other Keurig Dr Pepper news, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $32.55, for a total transaction of $390,600.00. Following the transaction, the insider directly owned 84,171 shares in the company, valued at approximately $2,739,766.05. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Angela A. Stephens sold 9,500 shares of the firm's stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $32.70, for a total value of $310,650.00. Following the completion of the transaction, the vice president directly owned 55,786 shares of the company's stock, valued at $1,824,202.20. The trade was a 14.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.34% of the company's stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc NASDAQ: KDP is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.

The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.